v3.26.1
STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2026
May 01, 2026
Dec. 31, 2025
Class of Stock [Line Items]      
Common stock, shares authorized 3,000,000,000   3,000,000,000
Common stock, par value $ 0.001   $ 0.001
Common stock, shares issued 2,997,301,029   2,939,061,314
Common stock, shares outstanding 2,997,301,029   2,939,061,314
Sale of Stock, Number of Shares Issued in Transaction 42,500,000    
Exchange for compensation $ 15,739,715    
Stock issued for compensation 239,055    
Common stock Issuable $ 240,000  
Stock issuable shares issued 240,000,000    
Exercise price   $ 0.0001  
Proceed in cash $ 513,000    
Facility description As of the date of this report, an aggregate of approximately $863,000 has been funded through multiple tranches under the Facility. The remaining balance of up to $2,207,000 is available for future funding, subject to the terms and conditions of the Agreement. See Note 12.    
Consulting Services [Member]      
Class of Stock [Line Items]      
Prepaid warrant   $ 3,000,000  
Warrant exercise price   $ 0.05  
Minimum [Member]      
Class of Stock [Line Items]      
Share price $ 0.014    
Maximum [Member]      
Class of Stock [Line Items]      
Share price $ 0.019    
Special 2020 Series A Preferred Control Share [Member]      
Class of Stock [Line Items]      
Preferred stock,shares authorized 20,000,001    
preferred stock, par value $ 0.001    
preferred stock, shares issued 1    
preferred stock, shares outstanding 1